Tidal Investments’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.3M Sell
1,309,258
-475,678
-27% -$8.01M 0.04% 412
2026
Q1
$33.1M Buy
1,784,936
+743,482
+71% +$14M 0.07% 254
2025
Q4
$15.1M Sell
1,041,454
-658,248
-39% -$10.5M 0.04% 361
2025
Q3
$30.1M Buy
1,699,702
+374,233
+28% +$7.76M 0.06% 245
2025
Q2
$31.1M Buy
1,325,469
+566,522
+75% +$14M 0.19% 131
2025
Q1
$20.9M Buy
758,947
+268,363
+55% +$10.3M 0.17% 156
2024
Q4
$25.8M Buy
490,584
+363,684
+287% +$22.7M 0.2% 108
2024
Q3
$11.2M Buy
126,900
+51,196
+68% +$6.1M 0.12% 154
2024
Q2
$11.7M Buy
75,704
+54,029
+249% +$10.6M 0.16% 127
2024
Q1
$4.54M Buy
+21,675
New +$4.44M 0.08% 262

Other funds holding MRNY

Tidal Investments's MRNY Position: Q2 2026 in Review

Tidal Investments reduced its YieldMax MRNA Option Income Strategy ETF (MRNY) stake by 27% in Q2 2026, selling an estimated $8.01M and leaving 1,309,258 shares worth $25.3M. The position accounts for 0.04% of the portfolio, ranked #412.

Tidal Investments first reported a position in MRNY in Q1 2024 and has held it in 10 quarters since. The position peaked at $33.1M in Q1 2026. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.

  • Tidal Investments held 1,309,258 shares of YieldMax MRNA Option Income Strategy ETF worth $25.3M as of Q2 2026.
  • Tidal Investments sold 475,678 YieldMax MRNA Option Income Strategy ETF shares in Q2 2026, an estimated $8.01M.
  • YieldMax MRNA Option Income Strategy ETF made up 0.04% of Tidal Investments's portfolio in Q2 2026, its #412 holding.
  • Tidal Investments first reported a position in YieldMax MRNA Option Income Strategy ETF in Q1 2024 and has held it in 10 quarters since.
  • Tidal Investments's YieldMax MRNA Option Income Strategy ETF position peaked at $33.1M in Q1 2026.
  • 10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.